Evidence map›Paper›PMID 22101158›Full record

ArticleImmunity2011

A role for differential variable gene pairing in creating T cell receptors specific for unique major histocompatibility ligands.

Brian D Stadinski, Peter Trenh, Rebecca L Smith, Bianca Bautista, Priya G Huseby, Guoqi Li, Lawrence J Stern, Eric S Huseby

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 85 citations in OpenAlex.

  1. Identification of multiple public TCR repertoires in chronic beryllium disease.Journal of immunology (Baltimore, Md. : 1950) · 2014
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The partitioning of TCR repertoires by thymic selection.The Journal of experimental medicine · 2024
    Review
  8. Review
  9. Article
  10. I-ANature immunology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Brian D StadinskiDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Peter Trenh
Rebecca L Smith
Bianca Bautista
Priya G Huseby
Guoqi Li
Lawrence J Stern
Eric S Huseby
University of Massachusetts Chan Medical School · US

Funding

Technologies for Human Cellular ImmunologyU19AI057319 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIBRATY, DANIEL H. · 2003 to 2013
$34.4M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Structure and Function of MHC ProteinsR37AI038996 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 2008 to 2017
$4.1M
Structure and Function of Class II MHC ProteinsR01AI038996 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J · 1996 to 2006
$1.6M
Production of animal models to define how CTLA-4 impacts to T1D susceptibilityRC1DK086474 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KANG, JOONSOO · 2009 to 2010
$976k
Inflammatory and Suppressive mechanisms of CNS autoimmunityR21AI088495 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HUSEBY, ERIC S · 2010 to 2011
$409k
NIAID NIH HHS R01 AI038996NIAID NIH HHS R01-AI-38996NIAID NIH HHS R21 AI088495NIAID NIH HHS R37 AI038996NIAID NIH HHS T32 AI007349NIAID NIH HHS U19 AI057319NIAID NIH HHS U19-AI-57391NIDDK NIH HHS DK32520NIDDK NIH HHS P30 DK032520NIDDK NIH HHS RC1 DK086474PHS HHS RAI088495A
6 · The paper itself

Abstract

A limited set of T cell receptor (TCR) variable (V) gene segments are used to create a repertoire of TCRs that recognize all major histocompatibility complex (MHC) ligands within a species. How individual αβTCRs are constructed to specifically recognize a limited set of MHC ligands is unclear. Here we have identified a role for the differential pairing of particular V gene segments in creating TCRs that recognized MHC class II ligands exclusively, or cross-reacted with classical and nonclassical MHC class I ligands. Biophysical and structural experiments indicated that TCR specificity for MHC ligands is not driven by germline-encoded pairwise interactions.Rather, identical TCRβ chains can have altered peptide-MHC (pMHC) binding modes when paired with different TCRα chains. The ability of TCR chain pairing to modify how V region residues interact with pMHC helps to explain how the same V genes are used to create TCRs specific for unique MHC ligands.

Indexed as

AnimalsCross ReactionsHistocompatibility AntigensLigandsMiceMice, Inbred C57BLMice, KnockoutModels, MolecularPeptidesProtein BindingProtein ConformationReceptors, Antigen, T-Cell, alpha-betaThymus GlandT-LymphocytesHistocompatibility AntigensLigandsPeptidesReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID22101158
PMCPMC3253227
OpenAlexW2081090613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.